European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Amgen N.V., Machelen, Belgium

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Amgen N.V.

Identification

Kbo
Crossroads Bank for Enterprises (KBO) 0439.652.401
Lei
5493007TDQLA2Z7RB387
EUID
BEKBOBCE.0439.652.401

Address

Telecomlaan 5-7, 1830 Machelen, Belgium
Sint-Lambrechts-Woluwe, Belgium
Bruxelles, Belgium

Corporate purpose

46.46
Wholesale of pharmaceutical and medical goods
46.46
Wholesale of pharmaceutical goods

Financials

History

Persons

Network

Loading network

JOBS AT NORTH DATA

  • Video Producer
  • Working Student Customer Service
  • Modern Java Developer

Publications

7 Nov 2025
No longer Director: Heba Elmorshedy · Director (3)
1 Nov 2025 via Amgen Inc.
EU funding: Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies
24 Jun 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024 · CEO: Sara Schaufelberger · Board (3) …
17 Jun 2025 via Association Generale de l'Industrie du Medicament - Algemene Vereniging Van de Geneesmiddelenindustrie also 05/04/2022
No longer Member of the board: Association Generale de l'Industrie du Medicament - Algemene Vereniging Van de Geneesmiddelenindustrie
1 May 2025 via Actelion Pharmaceuticals Ltd.
EU funding: Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG
21 Nov 2024
Director: Heba Elmorshedy, Sara Schaufelberger · Capital: €173,525 · Company statute
25 Sept 2024 via Amgen Research (Munich) GmbH
EU funding: Synthetic hEalthcare dAta goveRnanCe Hub
24 Sept 2024
Director: Gabor Sztaniszlav · Director (2)
28 Aug 2024
Managing Director: Gabor Sztaniszlav · No longer Director: Gwenaël Caesens · Director (2)
28 Jun 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · CEO: Gabor Sztaniszlav · Board (1) …
29 Mar 2024 via Association Generale de l'Industrie du Medicament - Algemene Vereniging Van de Geneesmiddelenindustrie also 24/04/2023
Member of the board: Association Generale de l'Industrie du Medicament - Algemene Vereniging Van de Geneesmiddelenindustrie
1 Oct 2023 via Eli Lilly Export SA
EU funding: INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
28 Jun 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · CEO: Gabor Sztaniszlav · Board (2) …
25 May 2023
Managing Director: Gabor Sztaniszlav · Director: Gwenaël Caesens, N.N. · No longer Director: Adam Stewart Elinoff · Authorized signatory (4)
28 Jul 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · CEO: Gabor Sztaniszlav · Board: Gwenaël Caesens, Adam Elinoff …
1 Oct 2021 in Hor
EU funding: Optimal treatment for patients with solid tumours in Europe through Artificial intelligence
11 Sept 2020
Director: Gabor Sztaniszláv · No longer Director: Catherine Boutremans
18 Aug 2020
Vice president: Justin Claeys
25 Feb 2020
Director: Adam Stewart Elinoff · Director: Justin Claeys · Authorized signatory (4)
2 Dec 2019
Authorized signatory (4) · Director (2)
1 Apr 2019 in Hor
EU funding: Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
8 Mar 2019
No longer Director: Corinne Buffet · Director (3)
14 Dec 2018
Authorized signatory (1)
23 Jul 2018
Persons
4 Jun 2018
Director (2) · Company statute
12 Mar 2018
Authorized signatory (1) · Address
16 Feb 2017
No longer Director: Yves Zinggeler · Director (3) · Branch Office Manager (2) · Authorized signatory (2)
1 Feb 2017 in Hor
EU funding: Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
1 Jan 2017 in Hor
EU funding: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
1 Jan 2017 in Hor
EU funding: ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064
29 Aug 2016
Annual report for the year ending 31/12/2015 (only deposited)
7 Oct 2015
Authorized signatory (3) · Branch Office Manager (1) · No longer Director (2)
6 Jul 2015
Annual report for the year ending 31/12/2014 (only deposited)
1 Jul 2015 in Hor
EU funding: Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
5 Aug 2014
Annual report for the year ending 31/12/2013 (only deposited)
22 Nov 2013
Director (2) · No longer Director (2) · Company statute
20 Nov 2013
Persons
9 Sept 2013
Annual report for the year ending 31/12/2012 (only deposited)
5 Nov 2012
No longer Director (4) · Authorized signatory (2)
24 Jul 2012
Annual report for the year ending 31/12/2011 (only deposited)
2 Aug 2011
Annual report for the year ending 31/12/2010 (only deposited)
27 Oct 2010
No longer Director (3) · Address
2 Aug 2010
Annual report for the year ending 31/12/2009 (only deposited)
8 Jul 2009
Annual report for the year ending 31/12/2008 (only deposited)
12 Jun 2009
Authorized signatory (1) · Auditor (1)
20 Feb 2009
Director (1) · No longer Director (1)
27 Aug 2008
Annual report for the year ending 31/12/2007 (only deposited)
17 Dec 2007
Persons · Company statute
3 Aug 2007
Annual report for the year ending 31/12/2006 (only deposited)
31 Aug 2006
Director (3)
31 Aug 2006
Managing Director (2) · Company statute
11 Aug 2006
Annual report for the year ending 31/12/2005 (only deposited)
8 Jul 2005
Annual report for the year ending 31/12/2004 (only deposited)
26 Apr 2005
Managing Director (1)
15 Feb 2005
No longer Director (4) · Authorized signatory (2) · Capital: €173,525 · Company statute
23 Jul 2004
Director (1) · No longer Director (1) · Auditor (1)
7 Jul 2004
Annual report for the year ending 31/12/2003 (only deposited)
18 Jan 2004
Managing Director (1) · No longer Director (1)
14 Jan 2004
Managing Director (1) · No longer Managing Director (1)
6 Jan 2004
Managing Director (1) · No longer Auditor (1)
18 Aug 2003
Annual report (only deposited)
13 Sept 2002
Annual report (only deposited)
22 Aug 2002
Managing Director (2) · Director (2)
15 Feb 2002
No longer Director (3) · Director (3) · Capital: €3,025,493
28 Nov 2001
Annual report (only deposited)
31 Oct 2000
Annual report (only deposited)
30 Aug 2000
Managing Director (2) · Director (2) · No longer Director (2)
8 Feb 2000
Annual report (only deposited)
1 Jun 1999
Director (1) · Managing Director (1) · No longer Director (1)
1 Jan 1998
Annual report for the year ending 31/12/1997 (only deposited)
20 Jun 1997
CEO (1) · Managing Director (1) · Address
24 Jan 1997
Managing Director (2) · Liquidator (1) · No longer Director (1) · Auditor (1)
1 Jan 1997
Annual report for the year ending 31/12/1995 (only deposited)
10 Oct 1995
Layoffs - Appointments
26 Nov 1993
Company statute
8 Apr 1993
Layoffs - Appointments
30 Dec 1992
Layoffs - Appointments
16 Apr 1992
Layoffs - Appointments
7 Feb 1992
Address · Company statute
1 Jan 1992
Annual report for the year ending 31/12/1991 (only deposited)
7 Sept 1991
Layoffs - Appointments
19 Mar 1991
Belgian Official Gazette
24 Oct 1990
Address
20 Jan 1990
Reg­is­tra­tion: 20/01/1990
There are no publications matching your search.

Mentions

18 Nov 2025 in Kbo
Director: Association Generale de l'Industrie du Medicament - Algemene Vereniging Van de Geneesmiddelenindustrie
31 Jul 2023 in Ler
Direct parent: Amgen Inc
31 Jul 2023 in Ler
Ultimate parent: Amgen Inc
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Amgen N.V., Machelen, Belgium" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.